Immunology

Immune therapies against chronic hepatitis B

Hepatitis B virus (HBV) infection is global in nature and induces several liver diseases, such as chronic hepatitis B (CHB), cirrhosis of the liver (LC) and hepatocellular carcinoma (HCC). A total of 882,000 patients died ...

Medications

New target structure against coronavirus

Fluoxetine, a common antidepressant, inhibits the SARS-CoV-2 coronavirus in cell cultures and in preparations from human lung tissue. This was demonstrated by researchers at Julius-Maximilians-Universität (JMU) Würzburg ...

Diseases, Conditions, Syndromes

A roadmap for the future of hepatitis B therapy development

Worldwide, 880,000 people die each year as a result of infection with the hepatitis B virus (HBV). Antiviral drugs that can suppress replication of the virus are available. However, these must be taken for decades, as there ...

Diseases, Conditions, Syndromes

Five facts about Bell's palsy

No one's exactly sure what causes Bell's palsy, a condition that causes sudden facial weakness on one side of the face. But the symptoms are unmistakable. Once the weakness, or paralysis, sets in—usually on one side of ...

Medical research

Uncovering the HIV life cycle

Though it has been eclipsed lately by SARS-CoV-2, there is another global epidemic still threatening people: HIV/AIDS. According to UNAIDS, a United Nations initiative, some 38 million people worldwide are currently infected ...

Diseases, Conditions, Syndromes

The best medicine for COVID-19 is prevention

Since the beginning of the COVID-19 pandemic, health care professionals have worked hard to develop treatments for patients, and they have learned to manage the risk of hospitalization and death from COVID-19.

page 2 from 11